Low access to insulin in poor countries hinders diabetes care

CIDRAP's Mary Van Beusekom covers the Access to Medicine Foundation's latest report 'What are pharma companies doing to expand access to insulin - and how can efforts be scaled up?'

In discussing the report findings the author states "Systemic, sustainable programs with regular evaluation are key, particularly as global demand for insulin rises".